Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
Study Information
Alliance Study ID: NCCTG-N00C3
NCT Study ID (ClinicalTrials.gov): NCT00027963
Disease or Cancer Type: Other Cancer
Alliance Study Chair: Charles L. Loprinzi, MD
Status: COMPLETED
Study Description
RATIONALE: Gabapentin may be effective in relieving pain and other symptoms of peripheral neuropathy. It is not yet known if gabapentin is effective in treating peripheral neuropathy in cancer patients undergoing chemotherapy.
PURPOSE: Randomized phase III trial to determine the effectiveness of gabapentin in treating pain and other symptoms of peripheral neuropathy in cancer patients undergoing chemotherapy.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information